219673 Sigma-AldrichCFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem
A cell-permeable bisaminomethylbithiazole compound that is reported to rescue/correct the folding defect of CFTR δF508 mutant via direct interaction.
More>> A cell-permeable bisaminomethylbithiazole compound that is reported to rescue/correct the folding defect of CFTR δF508 mutant via direct interaction. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: Cystic Fibrosis Transmembrane Conductor Regulator Mutant Corrector II, N-(2-(5-Chloro-2-methoxy-phenylamino)-4ʹ-methyl-[4,5ʹ]bithiazolyl-2ʹ-yl)-benzamide, Corr-4
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
421580-53-2 | C₂₁H₁₇ClN₄O₂S₂ |
价格及供货情况
产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
---|---|---|---|---|---|---|
219673-10MGCN |
|
10 mg |
|
— |
Product Information | |
---|---|
CAS number | 421580-53-2 |
Form | Light beige solid |
Hill Formula | C₂₁H₁₇ClN₄O₂S₂ |
Chemical formula | C₂₁H₁₇ClN₄O₂S₂ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
219673-10MGCN | 04055977200911 |
Documentation
CFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem MSDS
职位 |
---|
CFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem 分析证书
标题 | 批号 |
---|---|
219673 |
参考
参考信息概述 |
---|
Pedemonte, N., et al. 2010. Am. J. Physiol. Cell Physiol. 298, C866. Young, A., et al. 2009. Biochem. J. 421, 377. Wang, Y., et al. 2007. J. Biol. Chem. 282, 33247. Wang, Y., et al. 2007. Mol. Pharmacol. 71, 751. Wang, Y., et al. 2007. Biochem. J. 406, 257. Pedemonte, N., et al. 2005. J. Clin. Invest. 115, 2564. |